Startups
Indousrare
Edit

Indousrare

Trusted
https://indousrare.org/
Last activity: 06.10.2026
Active
Categories: BuildingDevelopmentDiagnosticsDrugEdTechHardwareLegalTechNonprofitResearchUniversity
Indo US Organization for rare diseases (IndoUSrare) is an independent non-profit organization focused on helping patients with rare diseases of Indian origin in the USA, India, and globally with a vision to build collaborative highway-bridges between the west and the east to accelerate research and development of diagnostics and therapies through education, advocacy, research, and grants.

IndoUSrare serves as a gateway to the highway-bridges between the USA, and the Indian subcontinent to accelerate research & development of Diagnostics, Drugs, Devices, Biologics, and Therapeutics for rare diseases.

The USA is the largest funder of biomedical research with a forward-looking regulatory framework for innovative new medicines including cell and gene therapies. India is the largest democracy with a genetically diverse population of over 1.3 Billion people. Yet, India accounts for less than 1% of the global clinical research footprint. IndoUSrare will address this gap through enabling education, awareness, advocacy, fostering research collaborations and patient engagement in global clinical trials.

Our Board of Directors:
Harsha K Rajasimha, Ph.D. Founder and Chairman
Sundeep Agrawal, MD, Colt Ventures
Charles Andres, Ph.D., JD, Wilson Sonsini Goodrich Rosati Law Firm
Narayanan Govindarajan, MS, UWorld
Reena Kartha, Ph.D., Center for Orphan Drugs, University of Minnesota
Frank Sasinowski, MS, MPH, JD, Regulatory Attorney, Hyman Phelps McNamara PC and Vice-chair of EveryLife Foundation for rare diseases.

Advisors:
-------------------------------
Stephen Groft, Pharm.D., Board Director of ICORD, Retired Director, NIH, Bethesda, MD
Nicole Boice, Global Genes and RARE-X, Orange County, CA
Ancha Baranova, Professor, George Mason University, Fairfax, VA

Team Members:
Srinivas Seshadri, Director of Roarforrare, SFBayarea
Likes
662
Followers
708
Followers
589
Mentions
16

Overview

Location
United States, Virginia, Herndon
Employees
11-50
Phone
+1 540-239-0465
Founded date
2019

Mentions in press and media 16

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Jul 8, 2026Lead America and Interfaith Communities to Celebrate Unity in Diversity at the Freedom 250 Liberty GalaHistoric American Freedom 250 Liberty Charity Gala - Lead America Announces Interfaith Leadership Alliance Led Community Celebration. Lead America Community Leaders Standing in Solidarity During COVID 19 Pandemic Invitation to Freedom250 Li...
Feb 27, 2026IndoUSrare's 2030 Vision to Transform Rare Disease Research: Diaspora Engagement, AI Innovation, Patient-Centered ActionInnovation in Rare Diseases: Dr. Kartha in Conversation with Professor Levine #RDDIndoUSrare Virtual Dialogue – February 28, 2026 | 10 AM ET | 8:30 PM IST At IndoUSrare, we work at the intersection of research, patient support, and global c...
Dec 19, 2025IndoUSrare Announces Winners of Pitch4RARE Startup Pitch Competition Advancing Rare Disease InnovationIndoUSrare announced GenoPhe Biotech Pvt Ltd and IUVA Labs as the winners of Pitch4RARE 2025. Attox Research Laboratories received special recognition. Pitch4RARE2025 featured an eminent judging panel representing leadership across industry...
Oct 29, 2025Indo US Bridging RARE Summit 2025 Unites Global Leaders to Accelerate Therapies for Rare DiseasesBridgingRARE Summit 2025 is focused on strengthening the 6 pillars to accelerate diversity and equitable access to rare disease research Meet the 2025 Abbey Meyers Khushi Bridging RARE Award Honorees Only 5 Days to go for the BridgingRARE S...
Sep 17, 2025IndoUSrare Announces 2025 Abbey Meyers Khushi Bridging RARE Award HonoreesMeet the 2025 Abbey Meyers Khushi Bridging RARE Award Honorees. Join us in person at the Bridging RARE Gala for a celebration of their leadership and impact. Join us in person for the Bridging RARE Gala on the evening of 2nd November 2025. ...
Apr 29, 2024Newborn Screening Emergency: Urgent Call for Action to Identify 10,000+ Undiagnosed Rare DiseasesRARE PRS #12 The push for a transformative U.S.-India partnership in newborn screening (NBS) sets the stage for a seismic shift in tackling rare diseases, spotlighting the need to prepare for the digital AI revolution in global healthcare. ...
Aug 1, 2023Asia and the Indian Subcontinent: A Vision for Clinical Studies of Rare Diseases with Varied Prevalence GloballyClinical Studies of Rare Diseases Without true international collaboration, there will continue to be gaps in global patient registries and incomplete data due to a lack of multicultural sampling of patients, which decelerates the developme...
Mar 20, 2023Global Registries Could Change the Lives of Hundreds of Millions of Rare Disease Patients EverywhereWhile an astounding number of patients are available for clinical trials worldwide, U.S. sponsors of potential treatments often fail to meet their target patient enrollment as they are mostly focused on the U.S. and E.U. markets during the ...
Feb 8, 2023Celebrating Rare Disease Day and 40 Years of the Orphan Drug Act Advocating for Rare Disease Patients and Their FamiliesFigure: A collage of selected art4rare submissions from 2021 and 2022 Our vision is to accelerate research and development of diagnostics and therapeutics through education, advocacy, training, research, digital patient engagement, new tech...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Indousrare

When was Indousrare founded?

Indousrare was founded in 2019.

What has the press written about Indousrare?

Parsers VC has collected 16 articles mentioning Indousrare, among them “Lead America and Interfaith Communities to Celebrate Unity in Diversity at the Freedom 250 Liberty Gala” (Jul 8, 2026) and “IndoUSrare's 2030 Vision to Transform Rare Disease Research: Diaspora Engagement, AI Innovation, Patient-Centered Action” (Feb 27, 2026).

Is Indousrare still active?

Yes, Indousrare is active; its latest activity on Parsers VC dates from Oct 6, 2026.